Translate this page into:
Opinions, Attitudes, and Prescribing Practices of Oral Contraceptive Pills of General Practitioners and Gynecologists in India
Address for correspondence Sandeep Kumar, MS, FRCS, PhD, MMSc, Department of Surgery, King George's Medical University, B 52, J Park, Mandir Marg, Mahanagar, Lucknow, 226 006 Uttar Pradesh, India (e-mail: profsandeepsurgeon@gmail.com).
This article was originally published by Thieme Medical and Scientific Publishers Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.
Abstract
Background
To study the prescription behavior of oral contraceptive pills (OCPs) by physicians, gynecologists, and alternative medicine practitioners (AMPs).
Materials and Methods
Close-ended questionnaire-based cross-section study was performed between 1st September 2012 and 28th February 2014 in three groups of responders, i.e., AMP, general medical practitioners (GMPs), and obstetricians and gynecologists (ObGy). A stratified random cluster sample was used. Data of 400 subjects in all three groups were obtained using both univariate and multi-variate sophisticated statistical analyses for analyzing attitude and practices and were recorded on an ordinal scale using appropriate non-parametric test.
Results
Of the 1,237 subjects surveyed, 400 completed questionnaires were received from each of the three groups viz; AMPs, GMPs, and ObGy. Remaining 37 incomplete questionnaires were not included in the final analysis.
Conclusion
There are equal misconceptions regarding OCPs among users and prescribing physicians. Preference for OCPs in married and unmarried women is also equally low. OCP usage and their prescription practices can be improved by removing potential barriers, developing public–private partnership, and training promoters.
Keywords
oral contraceptive pills
birth rates prescribing behavior
general practitioners
gynecologists
Introduction
India was one of the first countries to have launched the National Family Welfare Program (NFWP) in 1952, which aimed to reduce birth rates as a part of the First Five Year Plan (1951–56). The NFWP has since grown and undergone significant transitions especially in terms of financial investment, geographic reach and access, quality of services, and the range of contraceptive methods offered. Consequently, the national total fertility rate, which used to be as high as 3.2 in 2000 decreased to 2.3 in 2016. However, contraceptive choice remains limited, thereby restricting last mile coverage of the unmet need for family planning.
The family planning program currently offers seven contraceptive methods: six methods for spacing—condoms (for both males and females), oral contraceptive pills and emergency contraceptive pills (OCPs and ECPs), intra-uterine contraceptive device, injectable contraceptives, lactational amenorrhea method, and the standard days method, and permanent method for limiting—sterilization (vasectomy/tubectomy). However, female sterilization remains the most preferred method of contraception by and large, with male sterilization being the lowest. In fact, female sterilization has remained the choice method of contraception for women, in general, and specifically among poorly educated and illiterate women from lower socio-economic strata.1 Family planning for the vast majority of Indians, therefore, remains female-centric and terminal method centric. Poor utilization of spacing methods leads to health complications resulting in poor maternal and child health.2 OCPs contain low doses of two hormones; progestin and estrogen like the natural hormones progesterone and estrogen in a woman's body. Their mechanism of action for contraception is primarily by preventing ovulation. Combined oral contraceptives are also called “the pill,” low-dose combined pills, OCPs, and OCs. Their failure rate is less than one pregnancy per 100 women using OCPs over the first year (3 per 1,000 women), and there is no delay in return of fertility after OCPs are stopped.3 Therefore, OCPs are expected to be a more popular contraceptive, but in India, only 3.1% of married women in reproductive age (15–49 years) use this method.4
A systematic view of the factors that influence access to and uptake of various methods of contraception necessitates the understanding of both client and provider perspectives. Although providers are essential partners in service programs, their perspectives have received remarkably little attention. Client–providers interactions have been found to be a major factor in clients' subsequent uptake of contraception. Not only do the providers' technical skills and knowledge affect service, but their opinions, attitudes, and advice strongly influence what services clients receive and their clients' subsequent behavior.5 As the literature about the provider's perspective is sparse and both gynecologists and general practitioners have unique opportunities to provide family planning, there is a strong need to study their opinions, attitudes, and prescribing behavior for OCPs. Therefore, this study was planned with objectives:
to study OCP prescription behavior among gynecologists, general medical practitioners (GMPs), and alternative medicine practitioners (AMPs) of a large capital city Lucknow (population 4 million), and
to develop strategies of popularizing the use of OCP in India both from provider's and end user's perspectives by provider's cross-sectional survey of availability, unmet needs of the users, perceived barriers, qualitative research, and focus group interviews of providers, married, and unmarried users.
Materials and Methods
Study design: This was a cross-sectional survey.
Settings and study participants: Gynecologists, general practitioners, and practitioners of other systems of medicine, practicing in Lucknow city were included in the study.
Study period: The duration of the study was from September 2012 to April 2014.
Sampling and sample size: Stratified sampling procedure was adopted to include gynecologists, general practitioners, and practitioners of other systems of medicine. The sample size was estimated for descriptive studies. As there were no data available, a proportion of 50% providers was assumed to have greater than 75% score (third quartile median score) toward prescribing OCP. Accepting the type I error equal to 0.05 and expecting the absolute precision equal to 5%, a sample size of 384 was calculated. Approximately, 400 providers from each group of gynecologists, general practitioners, and AMPs were considered the appropriate number of subjects for the study.
Data collection instrument: The study used a questionnaire as a tool to record opinion, attitude, and practices of the prescriber. A questionnaire with a total of 25 close-ended questions and five open-ended questions was finalized after pilot testing on 20 subjects. Test–retest reliability and inter-observer reliability displayed more than 85% agreement.
Data collection process: A list of gynecologists, private practitioners, and practitioners of other systems of medicine were obtained from various hospitals including King George Medical University (KGMU) Hospital, Lucknow, Indian Medical Association, Associations of Private Gynaecologists, Lucknow, Nursing Home Association, and practitioners working in Lucknow and nearby areas. Gynecologist and private practitioners, women practitioners, qualified practitioners of Unani, Homeopathy, and Ayurveda (AYUSH) in government hospitals, clinics, and private practice both in urban and rural Lucknow were included. Subjects and responders were mostly busy doctors and had to be visited several times. Block filling of the questionnaire was also used at a time of conferences and meetings of the above associations. Several visits were made to the clinics of doctors after prior appointments, and, in some cases, impromptu drop-ins at their clinics were also employed for collecting data. Thus, overall, this data collection was a sampling of convenience; however, the objectives and study outcomes are unlikely to be biased by this method of sampling.
Statistical analysis: Descriptive statistics are presented as counts and percentages for categorical variables. The chi-square test was used to test differences among different groups. IBM-SPSS-21 Software was used for statistical analysis. For open-ended questions, themes were identified, categorized, and presented as counts and percentages.
Ethics issues: The study protocol was approved by the Institutional Human Ethics Committee of KGMU Lucknow. All data collection was done after obtaining written informed consent from the participant.
Results
A total of 1,500 participants were contacted of which 1,237 responded, therefore giving a response rate of 82.46%. Out of these, 1,200 filled the questionnaires fully and were included in analysis. This included 400 respondents from each of the three groups, viz obstetrics and gynecologists (ObGy) (group-1), GMPs (group-2), and AMPs (group-3). This was intentionally done, to keep the numbers same across the groups and achieve the minimum sample size. All group-1 respondents were at least MBBS and Masters or Diploma holders in Gynecology and Obstetrics. In group-2, 144 of the respondents were MD or had completed some other postgraduate qualification. All group-3 respondents were qualified practitioners who had received a bachelor's degree in one of the branches of AYUSH, viz, Bachelor of Homeopathic Medicine and Surgery, Bachelor of Ayurvedic Medicine and Surgery, or Bachelor of Unani Medicine and Surgery.
Distribution of females among three groups was 10.7, 0.5, and 12.1%.
Table 1 summarizes respondents' opinions and attitudes about OCP utility and their readiness for its prescription to their clients. ►Table 2 shows OCP prescription practices and opinions regarding correct practices. ►Fig. 1 depicts respondents' first preference of contraception for married and unmarried women. ►Table 3 summarizes attitudes and practices of respondents toward OCP promotion. ►Table 4 highlights themes about perceived OCP prescription barriers among respondents.
Variable | Alternative medical practitioners | General medical practitioners | Obstetrics and gynecologist | p-Value | |||
---|---|---|---|---|---|---|---|
n | % | n | % | n | % | ||
Impact on maternal and infant mortality rates by spreading the knowledge of OCP | |||||||
MMR and IMR will increase | 14 | 3.50 | 11 | 2.80 | 7 | 1.80 | <0.001 |
Hardly any change | 23 | 5.80 | 29 | 7.30 | 22 | 5.50 | |
Some decrement in MMR but not on IMR | 69 | 17.30 | 49 | 12.30 | 21 | 5.30 | |
Definitely MMR and IMR will decrease but not only with OCPs | 129 | 32.30 | 136 | 34.00 | 95 | 23.80 | |
OCP will play a major role in decreasing MMR and IMR | 165 | 41.30 | 175 | 43.80 | 255 | 63.80 | |
Liberal prescription of OCP will help in the reduction of abortion-related morbidity | |||||||
No effect | 21 | 5.30 | 22 | 5.50 | 7 | 1.80 | <0.001 |
Reduction in urban clients | 46 | 11.50 | 30 | 7.50 | 9 | 2.30 | |
Reduction in literate clients | 75 | 18.80 | 72 | 18.00 | 22 | 5.50 | |
Reduction in all women | 90 | 22.50 | 105 | 26.30 | 32 | 8.00 | |
Yes, significant reduction in abortion-related morbidity and its complication in women | 168 | 42.00 | 171 | 42.80 | 330 | 82.50 | |
Liberal prescription of OCP will support liberal sexual activity | |||||||
Yes, definitely in women of every age group | 73 | 18.30 | 63 | 15.80 | 55 | 13.80 | <0.001 |
Yes, significantly in literate women | 39 | 9.80 | 74 | 18.50 | 32 | 8.00 | |
Partially in literates | 97 | 24.30 | 96 | 24.00 | 33 | 8.30 | |
Partially in adolescents | 68 | 17.00 | 85 | 21.30 | 36 | 9.00 | |
No effect. It is happening any way with or without OCP | 123 | 30.80 | 82 | 20.50 | 244 | 61.00 | |
Availability of OCP in rural and urban areas | |||||||
Poor availability | 65 | 16.30 | 54 | 13.50 | 23 | 5.80 | <0.001 |
Available at chemist shop only | 110 | 27.50 | 104 | 26.00 | 31 | 7.80 | |
Available free of cost at urban health setup with limited supply but not available in rural areas | 52 | 13.00 | 78 | 19.50 | 49 | 12.30 | |
Readily available in urban health setup but not in rural and remote areas | 56 | 14.00 | 57 | 14.30 | 92 | 23.00 | |
Readily available free of cost both in urban, rural, and remote areas | 117 | 29.30 | 107 | 26.80 | 205 | 51.30 | |
Agreeing to accessibility of contraceptive methods to all women | |||||||
Not so readily | 55 | 13.75 | 26 | 6.50 | 15 | 3.80 | <0.001 |
Only if they demand | 183 | 45.75 | 128 | 32.10 | 39 | 9.80 | |
Only to married women | 47 | 11.75 | 24 | 18.50 | 34 | 8.50 | |
All types to contraception readily available | 79 | 19.75 | 107 | 26.80 | 146 | 36.50 | |
All contraception should be actively promoted | 36 | 9.00 | 64 | 16.00 | 166 | 41.50 |
Variable | Alternative medical practitioners | General medical practitioners | Obstetrics and gynecologist | p-Value | |||
---|---|---|---|---|---|---|---|
n | % | n | % | n | % | ||
Is history taking and internal pelvic examination important before prescribing oral contraceptive pill? | |||||||
No, not necessary | 129 | 32.30 | 119 | 29.80 | 10 | 2.50 | <0.001 |
Yes, if patient have some complaint | 106 | 26.50 | 91 | 22.80 | 13 | 3.30 | |
Yes, only history taking is good enough | 30 | 7.50 | 63 | 15.80 | 21 | 5.30 | |
Yes, both history taking and pelvic examination in high-risk patient only | 52 | 13.00 | 57 | 14.30 | 91 | 23.80 | |
Yes, both are mandatory | 83 | 20.80 | 70 | 17.50 | 261 | 65.30 | |
Is pill counseling essential before prescribing OCP? | |||||||
Not essential | 50 | 12.50 | 39 | 9.80 | 4 | 1.00 | <0.001 |
Only when patient insists | 64 | 16.00 | 32 | 8.00 | 7 | 1.80 | |
It is optional | 67 | 16.80 | 51 | 12.80 | 24 | 6.00 | |
Only in high-risk patient | 26 | 6.50 | 24 | 6.00 | 23 | 5.80 | |
Always essential | 193 | 48.30 | 254 | 63.50 | 342 | 85.50 | |
Prescribing oral contraceptive pill | |||||||
Not so readily | 65 | 16.30 | 121 | 30.30 | 7 | 1.80 | <0.001 |
Avoid due to side effect | 96 | 24.00 | 65 | 16.30 | 14 | 3.50 | |
Depends on the type of client | 184 | 46.00 | 132 | 33.00 | 188 | 47.00 | |
Most of times | 43 | 10.80 | 63 | 15.80 | 112 | 28.00 | |
Easily prescribe | 12 | 3.00 | 19 | 4.80 | 79 | 19.80 | |
Pill counseling practice | |||||||
Never | 19 | 4.80 | 51 | 12.80 | 5 | 1.30 | <0.001 |
If client demands | 116 | 29.00 | 85 | 21.30 | 21 | 5.30 | |
Occasionally | 91 | 22.80 | 59 | 14.80 | 12 | 3.00 | |
Most of times | 100 | 25.00 | 131 | 32.80 | 137 | 34.30 | |
Never prescribe OCP without counseling | 74 | 18.50 | 74 | 18.50 | 225 | 56.30 | |
Providing information for missed pills | |||||||
No | 57 | 14.30 | 53 | 13.30 | 4 | 1.00 | <0.001 |
In missed pills only | 76 | 19.00 | 48 | 12.00 | 22 | 5.50 | |
If client demand | 97 | 24.30 | 68 | 17.00 | 10 | 2.50 | |
Educating client | 9 | 12.30 | 75 | 18.80 | 31 | 7.80 | |
To all with pill counseling | 121 | 30.30 | 156 | 39.00 | 333 | 83.30 | |
How do you prescribe OCP | |||||||
Casually do | 129 | 32.30 | 119 | 29.80 | 10 | 2.50 | <0.001 |
Verbalize and take a commercial name | 106 | 26.50 | 91 | 22.80 | 13 | 13.30 | |
Write it and ask assistance to explain its use | 30 | 7.50 | 63 | 15.80 | 21 | 5.30 | |
Write it and thoroughly explain its use | 52 | 13.00 | 57 | 14.30 | 95 | 23.80 | |
Carry out check-up and do counseling with written prescription | 83 | 20.80 | 70 | 17.50 | 261 | 65.30 | |
Advice of side effect of OCP to user | |||||||
Simply mention SE | 133 | 33.30 | 90 | 22.50 | 22 | 5.50 | <0.001 |
Hand over written information of SE in vernacular | 34 | 8.50 | 29 | 7.30 | 11 | 2.80 | |
Exclude high-risk clients and explain SE without over-emphasizing | 25 | 6.30 | 27 | 6.80 | 34 | 8.50 | |
Emphasize SE to all clients | 123 | 30.80 | 125 | 31.30 | 67 | 16.80 | |
Emphasize SE to OCP prescription user | 85 | 21.30 | 129 | 32.30 | 266 | 66.50 | |
Impact of OCP on family planning after explaining its side effect | |||||||
Negative impact | 20 | 5.00 | 10 | 2.50 | 12 | 3.00 | <0.001 |
Negative impact in illiterates and less educated | 72 | 18.00 | 57 | 14.30 | 25 | 6.30 | |
No impact | 73 | 18.30 | 67 | 16.80 | 34 | 8.50 | |
Insignificant impact | 40 | 10.00 | 62 | 15.50 | 31 | 7.80 | |
Positive impact | 195 | 48.80 | 204 | 51.00 | 298 | 74.50 | |
Follow-up of patients after prescribing oral contraceptive pill | |||||||
Do not call patient for follow-up | 72 | 18.00 | 91 | 22.80 | 1 | 0.30 | <0.001 |
Seldom call if patient have problem | 189 | 47.30 | 133 | 33.30 | 48 | 12.00 | |
Regularly at 6 months | 41 | 10.30 | 50 | 12.50 | 31 | 7.80 | |
Regularly at 3 months | 36 | 9.00 | 77 | 19.30 | 75 | 18.80 | |
First in third month, second at sixth month, and then annual follow-up | 62 | 15.00 | 49 | 12.30 | 245 | 61.30 | |
Usual follow-up practice in OCP user client | |||||||
History of side effect only | 255 | 63.80 | 277 | 69.30 | 46 | 11.50 | <0.001 |
History and IPE | 8 | 2.00 | 5 | 1.30 | 12 | 3.00 | |
History, IPE, and BP | 52 | 13.00 | 46 | 11.50 | 31 | 7.80 | |
History, BP, IPE, and breast examination | 42 | 10.50 | 28 | 7.00 | 103 | 25.80 | |
History, BP, IPE, breast examination, and PAP smear | 43 | 10.80 | 44 | 11.00 | 208 | 52.00 | |
In gynecological consultation other than contraception practice, what do you do if the patient is using OCP? | |||||||
Consider OCP | 70 | 17.50 | 43 | 10.80 | 2 | 0.50 | <0.001 |
Casually listen and do not take interest | 28 | 7.00 | 21 | 5.30 | 11 | 2.80 | |
Thorough history of OCP usage | 146 | 36.50 | 167 | 41.80 | 42 | 10.50 | |
Thorough history of OCP usage and do physical examination | 72 | 18.00 | 100 | 25.00 | 108 | 27.00 | |
Thorough history, do physical examination, PAP smear, IPE, and reinforce continue usage of OCP | 84 | 21.00 | 69 | 17.30 | 237 | 59.30 |
Variable | Alternative medical practitioners | General medical practitioners | Obstetrics and gynecologist | p-Value | |||
---|---|---|---|---|---|---|---|
n | % | n | % | n | % | ||
Update oneself with recent guidelines for OCP prescription | |||||||
Do not require | 41 | 10.30 | 32 | 8.00 | 4 | 1.00 | <0.001 |
MRs | 132 | 33.00 | 82 | 20.50 | 27 | 6.80 | |
Colleagues and peers | 30 | 7.50 | 46 | 11.50 | 13 | 3.30 | |
News, publications, print media, and conferences | 89 | 22.30 | 86 | 21.50 | 66 | 16.50 | |
CMEs, MRs, colleagues, peers, news, etc. | 108 | 27.00 | 154 | 38.50 | 290 | 75.50 | |
Use of posters of OCP for promotion | |||||||
Not take care, let it languish | 18 | 4.50 | 9 | 2.30 | 0 | 0.00 | <0.001 |
Casually put it | 92 | 23.00 | 90 | 22.50 | 18 | 4.50 | |
Put in my chamber | 94 | 23.50 | 90 | 22.50 | 28 | 7.00 | |
Put it both in my chamber and patient waiting lounge | 75 | 18.80 | 91 | 22.80 | 161 | 40.30 | |
Choose the most important one for display | 121 | 30.30 | 120 | 30.00 | 193 | 48.30 | |
Methods to spread knowledge of OCP usage | |||||||
Newspaper, booklets | 33 | 8.30 | 19 | 4.80 | 5 | 1.30 | <0.001 |
TV advertisement and radio | 54 | 13.50 | 36 | 9.00 | 14 | 3.50 | |
Group discussion | 35 | 8.80 | 43 | 10.80 | 19 | 4.80 | |
One-to-one counseling | 32 | 8.00 | 15 | 3.80 | 11 | 3.50 | |
All of above | 246 | 61.50 | 287 | 71.80 | 351 | 87.80 | |
No, waste of money | 70 | 17.50 | 45 | 11.30 | 12 | 3.00 | <0.001 |
Not significantly | 110 | 27.50 | 114 | 28.50 | 47 | 11.80 | |
Improved continuation at a higher cost of dispensing | 58 | 14.50 | 87 | 21.80 | 36 | 9.00 | |
Reduce drop outs without affecting cost of dispensing | 54 | 13.50 | 69 | 17.30 | 74 | 18.50 | |
Improved continuation with lower cost of dispensing | 108 | 27.00 | 85 | 21.30 | 231 | 57.80 | |
Decrease OCP usage | 17 | 4.30 | 29 | 7.30 | 8 | 2.00 | <0.001 |
Cannot say | 168 | 42.00 | 123 | 30.80 | 73 | 18.30 | |
No significant effect | 78 | 19.50 | 120 | 30.00 | 81 | 20.30 | |
Significant effect on increasing OCP usage | 51 | 12.80 | 67 | 16.80 | 96 | 24.00 | |
OCP should be available in camouflage packets | 86 | 21.50 | 61 | 15.30 | 142 | 35.50 | |
Not necessary | 8 | 2.00 | 9 | 2.30 | 3 | 0.80 | <0.001 |
Only if they are interested | 48 | 12.00 | 29 | 7.30 | 10 | 2.50 | |
Only female health workers | 70 | 17.50 | 44 | 11.00 | 19 | 4.80 | |
Compulsory to female and optional to male workers | 89 | 22.30 | 97 | 24.30 | 53 | 13.30 | |
All health workers | 185 | 46.30 | 221 | 55.30 | 315 | 78.80 | |
No, OCP have nothing to do with sex education | 38 | 9.50 | 9 | 2.30 | 3 | 8.00 | <0.001 |
Yes, only as method of contraception | 66 | 16.50 | 47 | 11.80 | 41 | 10.30 | |
Yes and would emphasize on other methods of contraception too | 60 | 15.00 | 58 | 14.50 | 26 | 6.50 | |
Definitely and will verbally provide information on OCP usage | 122 | 30.50 | 178 | 44.50 | 95 | 23.80 | |
Educate about OCP usage by written information | 114 | 28.50 | 108 | 27.00 | 235 | 58.80 |
Obstetrics and gynecologist | General practitioners | Practitioners of alternative medicine | |
---|---|---|---|
Q26 Barriers in prescribing OCPs | Social barriers, high cost. Compliance and side effects. Logistic barrier, lack of awareness, and education. No barriers. |
Social, custom, and logistic barriers. Compliance and side effects. Improper counseling and practice barriers. No barrier |
Compliance and logistic barriers. Side effect and lack of information. Custom and practice barriers |
Q27 Major drawbacks of present-day OCPs | Breakthrough bleeding and side effects. Missed pill and daily intake. Improper counseling and lack of education. High cost. Not easily accessible. |
Poor compliance, side effects, and daily intake. No drawbacks. High cost and lack of availability. |
Side effects No drawback. Lack of education and awareness, high cost, and poor availability. |
Q28 Switching from one type of contraception to OCPs | Breakthrough bleeding, compliance, and side effects. Never. Sometimes if patient demands. |
Never. Poor compliance. Depends on patients. Not frequently. OCP is not a perfect method of contraception. |
Never. If patient demand. |
Q29 Fears/doubts in your mind in prescribing OCPs | Breakthrough bleeding, compliance, and side effects. No doubts. Missed pill, daily intake, and poor follow-up. Interference in the natural process |
No fear. Side effect. Patient compliance, poor availability, and failure of OCP. |
No doubts. Side effect. Lack of education and awareness. |
Q30 Free and frank opinion on liberal use of OCP | Free is usage recommended on medical ground after proper counseling, education, and follow-up to prevent unwanted pregnancy. Should be made readily available. Free usage in a monogamous relationship but not helpful in preventing sexually transmitted diseases. Free usage will help in reducing MMR and IMR. Apart from OCP other barrier methods should also be used. |
Free usage or liberal use of OCP must be encouraged after proper counseling, education, and awareness after medical examination and on medical prescription, which can help in population control. Free usage can lead to more liberal sex; therefore, free usage is not recommended. |
Encouragement of good-quality OCP for liberal use to prevent unwanted pregnancies and control population under strict medical prescription and education. Liberal usage of OCP can lead to its misuse. |
OCPs or contraceptive methods directly or indirectly reduce unwanted pregnancies and, thereby, reduce the risk of abortion and birth-related morbidity and mortality.2 Overall, AMPs and GMPs had less favorable opinions toward advantages of OCPs in comparison to gynecologists. Most of the AMPs, GMPs, and some of the gynecologists also opined that the liberal use of OCPs would lead to increased sexual activity. More than two-thirds of AMPs and GMPs were unaware of the availability of OCPs in urban and rural areas. Only one-thirds of AMPs and GMPs advocated for easy accessibility of OCPs, while most of the gynecologists favored easy accessibility (►Table 2).
World Health Organization (WHO) and various national guidelines have advocated contraceptive counseling using the “GATHER” approach and after thorough history taking and examination.3 However, AMPs and GMPs seem to be hesitant in doing so since more than half of them thought that thorough examination and history taking are not necessary for all women being considered for OCPs and they do not usually counsel to everybody. A less favorable attitude of AMPs and GMPs is also reflected in their OCP prescription practices, wherein more than one-third of them do not readily prescribe OCPs and their prescription is casual or even only verbal (mentioning the brand name) (►Table 3).
All three groups of respondents majorly chose to go with barrier contraception and did not prefer OCPs for either married or unmarried women (►Fig. 1).
Information regarding missed pills and side effects is given during counseling by only one-third of AMPs and GMPs and by most of the gynecologists. More than half of the respondents opined about the positive impact of information about side effects on OCP usage. Proper follow-up and thorough history taking and examination of OCP users are expected for the long-term continuation of OCPs. However, about two-thirds of AMPs and GMPs did not call clients for follow-up visits. Overall, gynecologists were found to be more alert about pill counseling, history taking, examination, explaining side effects, asking for follow-up, and in opportunistic scrutiny for the usage of OCPs and their examination (►Table 3).
Most of the participants were eager to update their knowledge about OCPs through various sources like mainly medical representatives (MRs) for AMPs and GMPs, and MRs as well as continuing medical education for gynecologists. More than half of AMPs and GMPs were reluctant to use posters, while three-fourth of gynecologists displayed them strategically. Most of the participants advocated all kinds of communication modes like print and multimedia for spreading the knowledge of OCPs and also endorsed the need for training of all health workers in OCP use and management. Two-third of gynecologists felt that prescriptions for longer durations such as 3 months instead of 1 month will help in improving compliance and reducing costs. Respondents had a mixed opinion regarding the strategy of distributing OCPs in the unnamed package to increase its acceptability and usage in rural areas, orthodox communities, and sexually active adolescents. Only half of the respondents favored joint sessions of sex education and OCP promotion.
Discussion
Our study shows less favorable attitudes and opinions and sub-optimal practices regarding OCP prescription among AMPs and GMPs. However, gynecologists have more favorable attitudes and most of them adhere to the standards of practice for OCP prescription.
Our study shows that AMPs and GMPs undermine direct and indirect non-contraceptive benefits of OCPs and it gets reflected in their lesser willingness and actual practice of ready prescription of OCPs. There were distinct differences regarding the knowledge of OCP prescription protocols among gynecologists and other practitioners. It is a known fact that knowledge improves attitudes which, in turn, influence practice. Other investigators have also reported that when compared with other specialists, gynecologists are more likely to prescribe OCPs as compared with GMPs.6,7,8
We have found inconsistencies in practices like not providing counseling to all users, informing about missed pills only on demand, not asking everyone to come to follow-up, not carefully assessing history at follow-up, and not performing opportunistic screening for OCP usage. Using standardized checklists and formats as envisaged in WHO Family Planning Global Handbook for Providers would facilitate the adoption of uniform practices.3
OCPs are cost-effective, reversible, and safe choices both for married and unmarried women. However, it still is not a popular mode among users of contraception, which was reflected in our study. Most of our study participants did not consider it as the first preference for contraception. This could be explained with perceived out-of-proportion apprehensions of providers for side effects, necessity of strict compliance, and regular follow-up. Hamani et al have reported similar misconceptions regarding OCPs among users and prescribing physicians.9,10 These misconceptions regarding side effects, breakthrough bleeding, compliance, and failure rates might be playing a role in reducing OCP preference in both providers and clients.
Our study respondents particularly gynecologists advocated continuous prescription for 3 months instead of 1 month for improving compliance and reducing cost. Some studies which have explored OCP compliance over a long time suggest that prolonged adherence to OCP regimes is threatened by the same factors which derail other long-term therapeutic medications—demographic factors, costs, and side effects. On the contrary, increased compliance and adherence were seen in women who designated a daily time slot for consuming OCPs.11 However, long-term prescription for OCPs has been found to be more affordable than monthly prescriptions.12 These studies, however, explore uptake and adherence to OCPs in different (western) socio-cultural and economic contexts. In countries like India where contraception uptake is tied to socio-cultural norms and government facilities provide OCPs almost free of cost, factors that govern poor consumption of OCPs need to be explored.13 The strategy to distribute OCPs in unnamed packages elicited mixed responses. Our respondents unanimously agreed on the need to train all health workers on OCP prescription, usage, and management. Currently, medical officers, staff nurses, auxiliary nurse midwives, and accredited social health activists working in government-run health centers are periodically trained in family welfare programs. Private hospitals also employ many paramedics and they can be engaged in counseling, follow-up, and promotion of contraception methods to ease the workload of private practitioners. Therefore, mechanisms for the training of these paramedics from the private sector need to be evolved, which would definitely increase the quality of care in OCP prescription and management.
Conclusion
Opinions and attitudes of AMPs and GMPs are less favorable toward OCP usage, and their prescription practices are suboptimal as well. This is despite the fact that the government of India is trying to promote OCP usage through intensive mass media and national guidelines. This can be improved by developing public–private partnership and imparting targeted training to them, via the use of specific service guidelines, which may lead to increased adherence to standard prescription practices among gynecologists, in turn increasing the preference for OCPs in married and unmarried women.
Compliance with Ethical Standards
The study was conducted as part of the Indian Council of Medical Research project, and complete adherence to prescribed ethical standards was followed including institutional ethical clearance and informed consent of all participants.
Author Contributions
S.K. conceived the study, wrote the research proposal, and was the principal investigator. V.D. with the help of all other authors designed and tested the questionnaire, conducted the survey, and computed the data. Y.P. provided the technical and clinical inputs. G.G. and A.P. did the statistical analyses. A.P. facilitated and provided inputs in content validity and logistics of data collection.
Conflict of Interest
V.D. received a salary as a research officer from the ICMR. The other authors report no conflict of interest.
Funding
The above work was supported by an ad hoc research scheme funded by the Indian Council of Medical Research –ICMR, New Delhi (Ref No.: 5/10/12/2009-RHN). The work of S.K. was funded as a research project by the ICMR.
References
- Factors explaining the dominion status of female sterilization in India over the past two decades (1992-2016): a multilevel study. PLoS One. 2021;16(03):e0246530.
- [CrossRef] [PubMed] [Google Scholar]
- India Brief 1- the status of family planning in India: an introduction. at: https://www.fhi360.org/sites/default/files/media/documents/india1-family-planning-status.pdf (accessed )
- [Google Scholar]
- Family planning - a global handbook for providers. WHO at: http://www.who.int/reproductivehealth/publications/fp-global-handbook/en/ (accessed )
- [Google Scholar]
- International Institute for Population Sciences (IIPS) and Macro International. NFHS-3 Fact Sheet 2009 at: http://rchiips.org/nfhs/pdf/India.pdf (accessed )
- [Google Scholar]
- Provider imposed restrictions to clients' access to family planning in urban Uttar Pradesh, India: a mixed methods study. BMC Health Serv Res. 2013;13(01):532.
- [CrossRef] [PubMed] [Google Scholar]
- Attitudes and prescribing preferences of health care professionals in the United States regarding use of extended-cycle oral contraceptives. Contraception. 2006;73(01):41-45.
- [CrossRef] [PubMed] [Google Scholar]
- Attitudes and prescribing patterns of extended-cycle oral contraceptives. Contraception. 2011;84(01):71-75.
- [CrossRef] [PubMed] [Google Scholar]
- Prescribing preferences and personal experience of female gynaecologists in Germany and Austria regarding use of extended-cycle oral contraceptives. Eur J Contracept Reprod Health Care. 2010;15(06):405-412.
- [CrossRef] [PubMed] [Google Scholar]
- Practices and knowledge of female gynecologists regarding contraceptive use: a real-world Chinese survey. Reprod Health. 2018;15(01):115.
- [CrossRef] [PubMed] [Google Scholar]
- Misconceptions about oral contraception pills among adolescents and physicians. Hum Reprod. 2007;22(12):3078-3083.
- [CrossRef] [PubMed] [Google Scholar]
- Strategies to improve compliance among oral contraceptive pill users: a review of the literature. Open Access J Contracept. 2014;5:17-22.
- [CrossRef] [Google Scholar]
- Financial implications of 12-month dispensing of oral contraceptive pills in the veterans affairs health care system. JAMA Intern Med. 2019;179(09):1201-1208.
- [CrossRef] [PubMed] [Google Scholar]
- Barriers to use contraceptive methods among rural young married couples in Maharashtra, India: qualitative findings. Asian J Res Soc Sci Humanit. 2015;5(06):18-33.
- [CrossRef] [PubMed] [Google Scholar]